Extended Data Table 2. Data collection and refinement statistics.
Structure | Human DRD2 (ΔN/ΔICL3T4L/ΔC)-Risperidone complex |
---|---|
| |
Data Collection | APS, GMCA/CAT 23ID-B/D, 10 μm microfocus beam |
| |
Crystals | 20 |
Resolution range | 30.00 - 2.90 (2.99 - 2.90) |
Space group | P212121 |
Unit cell Dimensions a, b, c (Å) | 50.98 72.52 151.31 |
Unique reflections | 12826 (889) |
Multiplicity | 5.5 (2.5) |
Completeness (%) | 97.3 (86.9) |
Mean 1/σ(l) | 15.2 (1.0) |
Rmerge (%) | 13.4 (73.8) |
CC1/2(%) | 99.4 (53.5) |
Refinement Statistics | |
Reflections used in refinement | 12826 (889) |
Reflections used for R-free | 622 (40) |
R-work (%) | 22.6 (37.4) |
R-free (%) | 24.9 (34.1) |
Number of Atoms | |
DRD2 | 1948 |
T4L | 1176 |
Risperidone | 30 |
Lipid and other | 82 |
Overall B-factors (Å2) | |
Receptor | 84.1 |
T4L | 97 |
Risperidone | 75.8 |
Lipids, water, other | 86.8 |
Model Statistics | |
RMSD-bonds (Å) | 0.004 |
RMSD-angles (°) | 0.56 |
Ramachandran favored (%)# | 97.36 |
Ramachandran allowed (%)# | 2.64 |
Ramachandran outliers (%)# | 000 |
Rotamer outliers (%)# | 0.67 |
Clashscore* | 399 |
Rmerge = Σhkl |I(hkl) − <I(hkl)>|/Σhkl(hkl), where <I(hkl)> is the mean of the symmetry equivalent reflections of I(hkl).
As defined in MolProbity.